osa and tirzepatide SURMOUNTs obstructive sleep apnea, what's next in advancing GLP-1s? Tirzepatide on obstructive sleep apnea-related

By activating both receptors, oxyntomodulin increases energy expenditure, reduces appetite, promotes weight loss, and improves glucose tolerance, showcasing the therapeutic potential of this dual mechanism [79]

timing and dose changes should involve a clinician

GLP-1, ,

Elevated levels of Lp(a) are a strong risk factor for having a heart attack due to atherosclerotic plaque buildup.[ref] Lipoproteins are fat-protein packages that transport cholesterol through the bloodstream, including LDL, HDL, and lipoprotein(a)

Health history: If you have conditions like diabetes, high blood pressure, or digestive issues, your provider may adjust the dose to make sure it works safely with your body

I cant wait to start my weight loss program